Recurrence_rates_of_treated_basal_cell_carcinomas._Part_2:_Curettage-electrodesiccation._This_is_the_second_article_in_a_series_that_reviews_the_experience_in_the_Skin_and_Cancer_Unit,_from_1955_through_1982,_with_the_treatment_of_basal_cell_carcinomas_(BCCs)._This_report_deals_with_2314_previously_untreated_(primary)_BCCs_removed_by_curettage-electrodesiccation._Multivariate_analysis_showed_that_increasing_lesion_diameter_(P_less_than_.001),_high-risk_anatomic_sites_(nose,_paranasal,_nasal-labial_groove,_ear,_chin,_mandibular,_peri-oral,_and_peri-ocular_areas)_(P_less_than_.001),_middle-risk_anatomical_sites_(scalp,_forehead,_pre-_and_post-auricular,_and_malar_areas)_(P_less_than_.001),_and_time-span_treated_(1955_to_1963)_(P_=_.012)_were_independent_risk_factors_for_high_recurrence_rates._The_patient's_age,_sex,_and_lesion_duration_before_treatment_did_not_affect_the_recurrence_rates._In_order_to_best_illustrate_our_current_experience_with_BCCs,_the_last_time-span_(1973_to_1982)_was_examined_in_detail._For_the_low-risk_sites_(neck,_trunk,_and_four_extremities),_BCCs_of_all_diameters_responded_well_to_curettage-electrodesiccation_with_an_overall_5-year_recurrence_rate_of_3.3%_(SE_=_1.5%)_determined_by_the_modified_life-table_method._In_the_middle-risk_sites_BCCs_less_than_10_mm_in_diameter_had_a_recurrence_rate_of_5.3%_(SE_=_2.7%)._Finally,_in_the_high-risk_sites,_lesions_less_than_6_mm_in_diameter_had_a_recurrence_rate_of_4.5%_(SE_=_2.6%)._Thus,_BCCs_less_than_6_mm_in_diameter,_regardless_of_anatomic_site,_as_well_as_selected_larger_BCCs_depending_on_their_anatomic_site,_are_effectively_treated_by_currettage-electrodesiccation.